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Abstract
Background: Phosphatidic acid (PA) is a key regulated intermediate and precursor for de novo biosynthesis of all
glycerophospholipids. PA can be synthesized through the acylation of lysophosphatidic acid (LPA) by 1-acyl-3-phosphate
acyltransferase (also called lysophosphatidic acid acyltransferase, LPAAT). Recent findings have substantiated the essential
roles of acyltransferases in various biological functions.
Methodologies/Principal Findings: We used a flow-injection-based lipidomic approach with ,200 multiple reaction
monitoring (MRM) transitions to pre-screen fatty acyl composition of phospholipids in the yeast Saccharomyces cerevisiae
mutants. Dramatic changes were observed in fatty acyl composition in some yeast mutants including Slc1p, a well-
characterized LPAAT, and Cst26p, a recently characterized phosphatidylinositol stearoyl incorporating 1 protein and
putative LPAAT in S. cerevisiae. A comprehensive high-performance liquid chromatography–based multi-stage MRM
approach (more than 500 MRM transitions) was developed and further applied to quantify individual phospholipids in both
strains to confirm these changes. Our data suggest potential fatty acyl substrates as well as fatty acyls that compensate for
defects in both Cst26p and Slc1p mutants. These results were consistent with those from a non-radioactive LPAAT
enzymatic assay using C17-LPA and acyl-CoA donors as substrates.
Conclusions: We found that Slc1p utilized fatty acid (FA) 18:1 and FA 14:0 as substrates to synthesize corresponding PAs;
moreover, it was probably the only acyltransferase responsible for acylation of saturated short-chain fatty acyls (12:0 and
10:0) in S. cerevisiae. We also identified FA 18:0, FA 16:0, FA 14:0 and exogenous FA 17:0 as preferred substrates for Cst26p
because transformation with a GFP-tagged CST26 restored the phospholipid profile of a CST26 mutant. Our current findings
expand the enzymes and existing scope of acyl-CoA donors for glycerophospholipid biosynthesis.
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Introduction
Glycerophospholipids are major components of cellular mem-
branes and are involved in a wide range of biological processes[1].
Most naturally occurring glycerophospholipids have a heteroge-
neous intramolecular acyl chain composition, usually with saturated
acyls at the sn-1 position and unsaturated acyls at sn-2.
Acyltransferases including glycerol-3-phosphate acyltransferase
(GPAT), 1-acyl-3-phosphate acyltransferase (AGPAT) (also called
lysophosphatidic acid acyltransferase, LPAAT), LPLAT (lysopho-
spholipid acyltransferase) and diacylglyceride acyltransferase fam-
ilies play essential roles in acyl substrate selection for deacylation
and reacylation reactions (Lands cycle) during glycerophospholipid
biosynthesis [2]. Two pathways for de novo glycerophospholipid
biosynthesis have been reported, using either glycerol-3-phosphate
or dihydroxyacetone phosphate and acyl-CoA as substrates to
synthesize lysophosphatidic acids (LPAs), the initial step of
phospholipid biosynthesis [3]. Lysophosphatidic acid is further
esterified at the sn-2 position with an acyl group to form
phosphatidic acid (PA), which is catalyzed by LPAAT. Recent
findings have further substantiated the essential roles of acyltrans-
ferases in membrane diversity, curvature, and asymmetric distribu-
tion of fatty acyls (FA) within individual phospholipids[4–6]. In
particular, LPAAT plays important roles in various organisms
[7–14]. Mutations in AGPAT2 (or LPAAT-b) cause congenital
generalized lipodystrophy, a syndrome with complete or nearly
complete loss of adipose tissue evident at birth [8]. The affected
children are prone to develop diabetes, hepatic steatosis, and
hyperlipidemia with age [10]. A recent study of Agpat2(2/2) mice
suggested that both dietary fat and hepatic triglyceride (TAG)
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biosynthesis via a monoacylglycerol pathway may contribute to
hepatic steatosis in these mice [9]. In contrast, increased expression
of LPAAT-b (AGPAT2) is associated with malignancy[11]. As such,
LPAAT-b may be an important enzyme in human tumor
proliferation and tumor survival[12]. LPAAT-b expression is
emerging as a prognostic marker and therapeutic target in
gynecologic malignancies [7]. AGPAT6 deficiency in mice reduces
body weight and white adipocyte size, alters fatty acid composition,
and causes subdermal lipodystrophy and resistance to obesity [13].
Plastid LPAAT is essential for embryo development in Arabidopsis
during the transition from the globular to the heart stage, and loss of
plastid LPAAT causes embryo lethality[14].
In Saccharomyces cerevisiae, PA can be synthesized de novo through
the acylation of glycerol-3-phosphate by Gat1p (also known as
Gpt2p) or Gat2p (also known as Sct1p) and subsequent acylation
of LPA by Slc1p or Slc4p (also known as Ale1p, Lpt1p, Lca1p)
[5;15;16]. A few recent studies have revealed that the S. cerevisiae
gene SLC4 or LPT1 encodes an acyl-CoA-dependent LPLAT
capable of acylating LPA, lysophosphatidylcholine, lysophospha-
tidylethanolamine, lysophosphatidylglycerol, lysophosphatidylino-
sitol and lysophosphatidylserine [17]. SLC1, together with SLC4,
encodes partially redundant LPAAT activity in S. cerevisiae [16].
The slc1Dslc4D double knockout is lethal, indicating that LPAAT
activity is essential in yeast [16].
Current approaches for evaluating acyltransferase activity are
mainly based on enzymatic assays monitored by quantification of
radioactive compounds via thin-layer chromatography [15–18]. In
recent years, mass spectrometry (MS)–based lipidomics approach-
es have been commonly used to study lipid metabolism in various
biological systems. For instance, shotgun lipidomic approaches are
widely used to study lipid metabolism in various models, mainly
based on unbiased profiling and tandem MS for individual classes
of lipids [19–21]. In this study, we used FA-based multiple reaction
monitoring (MRM) approaches to screen for potential acyltrans-
ferases in the EUROpean Saccharomyces Cerevisiae ARchive for
Functional analysis (EUROSCARF) library to characterize
potential substrates for annotated acyltransferase genes. We found
dramatic changes in fatty acyl profile in some mutants, such as
DSLC1 and DCST26, compared with wild-type yeast. Data from
our lipidomic analysis will provide information on the substrate
(acyl chain) specificity of any acyltransferase. Further, we
correlated our lipidomics results with data from acyltransferase
activity assays.
Results
We used an integrated lipidomic-based approach to directly
characterize potential fatty acyl substrates for known or putative
LPAAT acyltransferases (Figure 1). Briefly, flow-injection-based
MRM analysis of individual lipid species was utilized for rapid
screening of altered fatty acyls in the yeast S. cerevisiae mutants
(Figure 2). Selected strains, which in prescreening showed
significantly altered fatty acyl profiles in phospholipids, were
further investigated using a multi-stage LC-MRM approach (over
500 MRM transitions) for analysis of individual lipids to confirm
the results obtained through rapid-flow injection (Figure 3). Lastly,
LPAAT enzymatic activity was measured to confirm results
obtained by lipidomic analyses.
Sensitive fatty acyl–based MRM analysis of crude lipid
extract from yeast
Previous studies on phospholipid species in the yeast S. cerevisiae
indicated that it has a relatively simple phospholipid composi-
tion[21–23]. Most MRM-based lipidomic approaches have been
based on the MRM transition to polar head groups, which
provides information on both of the polar head groups and total
number of carbon-carbon double bonds of the two fatty acyl
chains in a phospholipid. Despite the relatively high sensitivity of
this approach, it does not yield detailed information on each fatty
acid. An additional screen of fatty acyl–based precursor ion scan is
usually required to obtain such information.
We used fatty acyl–based MRM transitions to screen for
individual phospholipids in yeast. The MRM transitions were
classified into different groups based on yeast fatty acyl
composition, i.e., FA 18:0, 18:1, 16:0, 16:1, 14:0, 14:1, 12:0 and
10:0. In the negative ESI mode, PE species ionize more readily
than PC species. With piperidine as a modifier, ionization of PE
species was enhanced by ,10 fold, which was much greater than
increases in ionization of PC species. Thus, it may be possible to
qualitatively profile PE species directly using MRM transitions of
[M2H]21 over individual fatty acyl ions[20]. PC could be
detected using [M+Cl]21 without overlapping with other phos-
pholipids. Thus, we applied chloroform:methanol:200 mM piper-
idine (1:1:0.05) as a mobile phase to directly introduce the sample
into the mass spectrometer for MRM analysis. This approach is
advantageous for the following reasons: (1) enhanced ionization of
all phospholipids, in particular PE and PS species in the negative
ESI mode [20]; (2) fatty acyl–based MRM yields better sensitivity
than polar-head MRM transitions; and (3) selection of an
appropriate mobile phase dramatically reduces carryover of sticky
phosphatidylserine in the machine lines and generates better peak
shape (data not shown), which facilitates high-throughput
screening. Furthermore, using an autosampler to manipulate
samples prevents manual error and is thus labor efficient.
Comprehensive analysis of individual lipids using a multi-
stage LC-MRM approach
Although the flow-injection-based MRM approach serves as a
rapid way to prescreen for the presence of altered fatty acyls in yeast
mutants, more accurate quantitation of certain lipid species, in
particular PE and PC, requires well-resolved chromatography
separation. We used a Luna silica column and a typical normal-
phase mobile phase system to develop a multi-stage LC-MRM
approach with over 500 MRM transitions in a 50-min run and
demonstrated that different classes of phospholipids could be
successfully separated. The rather large linear range usingMRM for
quantitation allowed the accurate analysis of major yeast phospho-
lipids in a single run. Among those phospholipids validated, PG
eluted first, followed by PE, PC, PI, PS and PA. PI and PS were not
completely resolved using this elution system, but the different
MRM transitions for these two classes of lipids in yeast allowed their
quantitation in a single run (Figure 3 and Table S1). Total ion
chromatograms of cst26D and slc1D cells were similar to that of wild-
type (Figure 3A–C). Levels of individual lipid species were
calculated by comparison with spiked internal standards.
Characterization of potential substrates for Slc1p using
mass spectrometry
Slc1p is the primary 1-acyl-sn-glycerol-3-phosphate acyltrans-
ferase mediating the incorporation of unsaturated acyl chains into
phospholipids during de novo synthesis [16]. As a positive control,
we examined whether a lipidomics approach could directly detect
Slc1p function, with confirmation by an in vitro radioactive
enzymatic assay.
ESI-MS was first applied to profile lipids in crude extracts of
wild-type and slc1D mutant of S. cerevisiae, and the results (Figure
S1A–C) were similar to our previous findings [24]. The slc1D cells
Acyl Substrates for LPAAT
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showed dramatic decreases in PI 30:0 (m/z 781), PI 28:0 (m/z
753), PI 28:0 (m/z 725), LysoPI 14:0 (m/z 545) and LysoPI 12:0
(m/z 517). Further precursor ion scanning based on the fragment
of phosphatidylinositol (m/z 241.0, C6H10O8P) for PI profiles
revealed the absence of saturated short-chain PI species including
PI 26:0, 28:0, 30:0, etc (Figure S1D–E). We next applied the fatty
acyl–based MRM approach to detect alterations in phospholipid
fatty acyl chains in crude lipid extracts of slc1D cells. Not
surprisingly, the composition of fatty acyls in slc1D phospholipids
differed substantially from that of wild type (Figure 2A–H). Of the
changes among the major fatty acyls, the levels of most 18:1-
contaning phospholipids were significantly lower in slc1D,
whereas the levels of most 16:1-containing phospholipids were
significantly higher (Figure 2B, 2C). The levels of most
phospholipids containing FA14:0 were significantly decreased
(Figure 2D, 2E). In addition, phospholipids containing short-
chain fatty acyls, such as FA 12:0 and FA 10:0, were nearly
absent in slc1D (Figure 2G, 2H). By contrast, most phospholipids
containing FA 16:1 and FA 14:1 were elevated in slc1D
(Figure 2C, 2F). Similar profile changes were observed using
normal-phase LC in combination with the multi-stage MRM
approach (Figure 3 and data not shown).
Characterization of potential substrates for Cst26p using
MS
Cst26p contains a 1-acylglycerol-3-phosphate acyltransferase
domain (Figure S2) and thus is a putative acyltransferase. We
investigated whether Cst26p had acyltransferase activity in the
yeast S. cerevisiae and, if so, which fatty acyls were its potential
substrates.
ESI-MS was first applied to profile lipids in crude extracts
of wild-type and cst26D of S. cerevisiae. Comparison of the
normalized lipid profiles for the wild type and cst26D revealed a
dramatic reduction in lipid species with m/z at 863 (PI 36:1)
(Figure S3A–B, representative data from rich medium). A
differential log ratio plot was generated to further compare
wild-type and cst26D lipid profiles, and ions at m/z 863 (PI 36:1)
were the most substantially regulated peaks (Figure S3C). There
were a few other differences as well, such as decreases in PI 34:1,
lysoPI 18:0 and lysoPI 16:0 in the mutant, and increases in PE
32:2, PI 32:2, PI 34:2 and lysoPI 16:1. These data indicate that
deletion of CST26 alters the fatty acyl composition of phospho-
lipids. Further fatty acyl–based precursor ion scanning at m/z
283.2 showed a dramatic decrease in FA 18:0-containing
phosphoinositides (Figure S3D–E).
Figure 1. Flow chart illustrating the lipidomic approach to screen and characterize fatty acyl substrates for potential
acyltransferases.
doi:10.1371/journal.pone.0011956.g001
Acyl Substrates for LPAAT
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Figure 2. Fatty acyl–based MRM analysis of individual lipids in cst26D and slc1D. Heat plot shows differential levels of individual lipid
species in mutants, as indicated by MRM measurement, compared with wild-type cells. (A) FA-18:0-containing phospholipids; (B) FA-18:1-containing
phospholipids; (C) FA-16:1-containing phospholipids; (D) FA-16:0-containing phospholipids; (E) FA-14:0-containing phospholipids; (F) FA-14:1-
containing phospholipids; (G) FA-12:0-containing phospholipids; (H) FA-10:0-containing phospholipids. *, p,0.05; **, p,0.005; ***, p,0.001
(significant increases are indicated by red asterisks, and significant decreases by black asterisks).
doi:10.1371/journal.pone.0011956.g002
Acyl Substrates for LPAAT
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The above-mentioned fatty acyl–based MRM approach was
applied to qualitatively assess differences in the composition of
certain individual fatty acyls in various phospholipids in cst26D
cells. This approach allowed direct visualization of fatty acyl
distribution in crude lipid extracts of yeast cells (Figure 2A–G,
representative data from YPD medium). Distinct changes in fatty
acyl composition among certain phospholipids were observed in
the CST26 mutant compared to wild type (Figure 2A–G), such as a
substantial reduction in FA18:0-containing PI species and
significant decreases in most other phospholipids containing a
single FA18:0 (Figure 2A).
We did not observe dramatic changes in most phospholipid
species containing FA18:1, except that PI18:0/18:1, PE18:1/16:0
and PS18:0/18:1 were decreased and a few short-chain FA-
containing species were significantly increased (Figure 2B).
However, no significant change was observed for all FA18:1-
based lysophospholipids. Overall results from the FA 18:1-based
MRM assay indicated that deletion of CST26 does not alter the
levels of FA 18:1 in cellular phospholipids (Figure 2B).
Significant decreases in most FA16:0-containing phospholipids
and lysophospholipids were observed in the CST26 mutant
(Figure 2D), indicating that FA 16:0 is also a potential fatty acyl
substrate of Cst26p. In contrast to the levels of FA 18:0- and FA
16:0-containing phospholipids in the CST26 mutant, most FA
16:1-containing phospholipids were elevated in the mutant
compared with wild type (Figure 2C). Similar results were
observed for the short-chain fatty acyl species 14:1, 12:0 and
10:0 (Figure 2E–G) and for cells cultured in SC medium. Further
normal-phase LC in combination with multi-stage MRM analysis
showed similar trends to those observed in the flow-injection
MRM analysis (data not shown).
Cst26p localizes to lipid droplets, and cst26D cells
expressing GFP-tagged CST26 have a normal lipid profile
To conclusively show that the observed changes in the lipid
profile were due to deletion of CST26, we transformed a GFP-
tagged Cst26p into a CST26 mutant strain. Cst26p localized to
lipid droplets (Figure 4A–B), as observed in GFP-tagged CST26
transformed cells. Moreover, the lipid composition of the
transformed cells was restored to that of wild-type cells, indicating
that the GFP-tagged Cst26p compensated for the loss of function
of the enzyme in the mutant. (Figure 4C, Figure S4).
Characterization of the substrate for Slc1p and Cst26p as
assessed by LPAAT activity
To further characterize the substrates of the two acyltrans-
ferases, we assessed LPAAT activity in the presence of a synthetic
substrate, C17 LPA, and various other acyl-CoA substrates.
Compared to wild type, cst26D cells produced significantly lower
levels of PA17:0/18:0, PA17:0/16:0, and PA17:0/14:0, whereas
slc1D cells had a defect in conversion of LPA into PA17:0/18:1,
PA17:0/10:0, PA17:0/12:0 and PA17:0/14:0 (Figure 4D). Thus,
the fatty acyl substrates for Cst26p include 18:0-acyl-CoA, 16:0-
acyl-CoA, 17:0-acyl-CoA and 14:0-acyl-CoA, whereas those for
Figure 3. Multi-stage MRM analysis of individual lipids in each class (listed in Table S1) after normal-phase LC separation. (A) wild
type; (B) DCST26; (C) DSLC1. PG, phosphatidylglycerol; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PI, phosphatidylinositol; PS,
phosphatidylserine; PA, phosphatidic acid. Y-axis: intensity, counts per second (CPS). The Olive lines on the left and right side of PC show switching
time points for scheduled MRM transitions.
doi:10.1371/journal.pone.0011956.g003
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Slc1p include 18:1-acyl-CoA, 14:0-acyl-CoA, 12:0-acyl-CoA and
10:0-acyl-CoA (Figure 4D).
LC-MS analysis of neutral lipids in cst26D and slc1D cells
Dramatic decreases in short-chain TAG species, including
TAG40:1, 42:1 and 44:1, were observed in slc1D cells, accompa-
nied with an obvious increase in TAG48:3 (Figure 5). Short-chain
diacylglycerol (DAG) species, including DAG26:0, 28:0 and 30:0,
were also dramatically decreased (data not shown). Overall,
changes in fatty acyl composition of both TAG and DAG species
showed trends similar to those observed for phospholipids in slc1D
cells. There were no significant changes in individual TAG or
DAG species in cst26D cells compared with wild type (data not
shown).
Discussion
In recent years, MS has been widely used in a number of studies
investigating lipid metabolism] [19;21;22;25–27]. In particular,
the introduction of tandem MS has spurred the development of
various quantitative approaches, such as precursor ion scanning,
neutral loss scanning, and MRM scanning, for targeted lipidomic
analysis of complex samples[22;28;29]. Precursor ion scanning of
Figure 4. Localization of Cst26p in Dcst26 cells transformed with GFP-tagged Cst26 and LPAAT activity assay. (A) Micrographs of
DCST26 cells transformed with the empty vector. DIC, differential interference contrast. (B) flurescence microscopy ofDCST26 cells transformed with
GFP-tagged Cst26. (C) PI 34:1 and PI36:1 levels were restored in the CST26-transformed DCST26 mutant; (D) In the LPAAT activity assay, CST26 shows
acyltransferase activity toward 18:0, 17:0, 16:0, 14:0 (blue rectangles) with 16.7% of PA17:0/18:0, 65.1% of PA17:0/17:0, 28.5% of PA17:0/16:0 and
65.8% of PA 17:0/14:0 when compared with corresponding PA in wild type, whereas SLC1 shows activity toward 10:0, 12:0, 14:0 and 18:1 (red
rectangles) with 29% of PA17:0/10:0, 19% of PA17:0/12:0, 52% of PA17:0/14:0 and 76% of PA17:0/18:1 when compared with corresponding PA in wild
type. Levels of individual PA species were expressed as normalized intensity to internal standard PA14:0/14:0.
doi:10.1371/journal.pone.0011956.g004
Acyl Substrates for LPAAT
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individual fatty acyls has been used to investigate fatty acyl profiles
of phospholipids[30]. Fatty acyl composition of complex lipids can
also be rapidly characterized by collision-induced dissociation MS
[31], but this method does not provide information on fatty acyl
composition among different classes of phospholipids and lysopho-
spholipids. Recently, FA-based MRM approaches have been
shown to provide such direct information[23;32]. In this study, we
used chloroform:methanol (1:1) containing 5 mM piperidine as a
mobile phase and an autosampler to introduce crude lipid extract
directly into a triple-quadrupole mass spectrometer, which allowed
the sensitive and qualitative analyses of major yeast phospholipids
within 2 min. This simple approach serves as a rapid tool to
investigate potential fatty acyl substrates for known and putative/
unknown acyltransferases in yeast. Of those potential acyltrans-
ferases, we screened (data not shown and ongoing work) fatty acyl
profiles of cst26p and slc1p, which we found differed substantially
from the wild-type profile (Figure 2A–H). Using this approach, we
also observed dramatic changes in the profiles for other well-
characterized acyltransferases, including lpt1p (data not shown and
ongoing work).
However, PC species were poorly ionized in negative ESI mode,
most likely due to ion suppression from other phospholipids (PI,
PE and PS) when direct infusion or flow injection was utilized. A
more comprehensive multi-stage LC-MRM approach was devel-
oped that provided in-depth and accurate analysis of individual
lipid species in each class (Figure 3 and Table S1). Using a normal-
phase column for lipid separation, the multi-stage LC-MRM
increased MS signals of PC species by over 10 fold, allowing
accurate quantification of most PC and PE species in a single LC-
MS run. Provided with suitable internal standards, minor lipid
species including lysophospholipid species could also be accurately
quantified. For instance, lysoPE species were coeluted with PC
species, while LysoPI, LsoPC, LysoPA and LysoPSspecies were
eluted within the period from 40 to 50 min (data not shown).
Characterization of fatty acyl substrates for a potential
acyltransferase using an enzymatic activity assay usually requires
the purification of the protein or isolation of microsomal fractions
as well as radioactive 14C-labeled glycerol 3-phosphate or 14C-
labeled acyl-CoA [15–18]. Through direct analysis of cellular
phospholipids using the LC-based fatty acyl MRM approach, we
obtained additional and direct in vivo information that enabled
rapid characterization of fatty acyl preference of a potential
acyltransferase.
The decreased content of the major FA 18:1 in most
phospholipids and lysophospholipids in slc1D cells suggests that
FA 18:1 is a major substrate for Slc1p (Figure 2B). Increases in the
content of other unsaturated fatty acyls such as FA 16:1 and FA
14:1 could be due to upregulation of another acyltransferase(s) that
utilizes these unsaturated fatty acyls as substrates (Figure 2C–F). In
addition, changes in fatty acyl composition of slc1D indicate that
Figure 5. Triacylglycerol (TAG) profiles in slc1D cells. (A) wild-type; (B) slc1D. Levels of short-chain TAG species, including TAG40:1, TAG42:1 and
TAG44:1, were dramatically decreased in the slc1-deficient mutant.
doi:10.1371/journal.pone.0011956.g005
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PLoS ONE | www.plosone.org 7 August 2010 | Volume 5 | Issue 8 | e11956
FA 14:0 is also potential substrate of this acyltransferase. Depletion
of phospholipids containing short-chain fatty acyls suggests that
Slc1p is the main acyltransferase for short-chain fatty acyl donors
including FA 12:0 and FA 10:0 (Figure 2G, H). The results from
our lipidomic analysis were consistent with the LPAAT enzymatic
assay for Slc1p, which demonstrated that this acyltransferase
incorporated FA 18:1, FA 16:0, FA 14:0, FA 12:0 and FA 10:0
into LPA (Figure 4D).
Recently, Guedard et al. reported that Psi1p (Cst26p) is
responsible for the stearic acid enrichment that is characteristic
of phosphatidylinositol in yeast, which explains why only PI
species containing FA18:0 were dramatically decreased in yeast
deleted for CST26 [26]. However, a domain analysis of the
acyltransferase encoded by CST26 suggested that this enzyme is
specifically involved in the conversion of LPA to PA (Figure S2).
The specific changes in lipid composition in the CST26 mutant
indicated that the acyltransferase encoded by CST26 is involved in
the transfer of FA 18:0 and FA 16:0 (Figure 2A, D). Decreases in
lysophospholipids 18:0 (lysoPI 18:0, lysoPE 18:0, lysoPC 18:0, and
LysoPG 18:0) in CST26 mutant cells indicated alternative
pathways to sequester lysophospholipids, which would be expected
to increase in cells lacking Cst26p. As a consequence of the
decrease in FA 18:0 or FA 16:0 in cellular phospholipids, a
relatively higher proportion of other FA was incorporated into
phospholipids.
Fluorescence microscopy of GFP-tagged Cst26p indicated that
the protein localized to lipid droplets (Figure 4A–B), consistent
with previous results [33]. The levels of major species that were
decreased in the CST26 mutant (PI species with m/z 863 and 835)
were restored in transformed cells, and the lipid profile of
transformed cells was similar to that of wild type (Figure 4C,
Figure S4).
In the yeast S. cerevisiae, SLC1 encodes the main LPAAT
acyltransferase[5]. SLC4 (ALE1, YOR175C), which encodes a
membrane-bound O-acyltransferase and a lysophospholipid acyl-
transferase, is the key component of the Lands cycle for
lysophospholipid acyltransferases (Figure 6) [16;17;34;35]. Inter-
estingly, Slc1p has Mg2+-dependent acyltransferase activity toward
lyso forms of phosphatidylserine and phosphatidylinositol, whereas
SLC4 also encodes a second LPAAT in S. cerevisiae[16]. Lipid
analysis from slc1D and slc4D cells using traditional MS
approaches revealed similar in vivo phospholipid profiles but did
not convey information on fatty acyl composition [16]. Using our
current approach, we systematically investigated the fatty acyl
composition of phospholipids in the yeast S. cerevisiae and thus
directly provided the probable in vivo function of SLC1 and other
genes. When applied to cst26D cells, our data indicated that
Cst26p is another LPAAT that primarily uses FA 18:0 and FA
16:0 as the substrates in the yeast S. cerevisiae. These results were
consistent with our LPAAT activity data, which showed that
Cst26p is specific for saturated fatty acyl-CoAs (18:0, 17:0, 16:0,
14:0) whereas Slc1p is specific for FA 18:1, 14:0, 12:0, and 10:0
acyl-CoAs (Figure 4D). While both proteins possess an acyltrans-
ferase domain and prefer different fatty acyls as their main
substrates, the lipid profile of the double knockout of SLC1 and
YBR042C showed an additive effect that is all changes in SLC1
and YBR042C mutants (data not shown, ongoing project). There
is no distinct phenotype change observed for both mutants. It will
be interesting to look into effects of temperature shift as well as
chemical stress on both mutants as well as double knockout mutant
(ongoing project).
To the best of our knowledge, this is first evidence indicating
that Cst26p is a LPAAT acyltransferase having FA18:0, 17:0, 16:0,
and 14:0 acyl-CoA as its preferred substrates. We also report that
Figure 6. Biosynthesis of phospholipids in the yeast S. cerevisiae. G-3-P, glycerol 3-phosphate; DHAP, dihydroxyacetone phosphate; LPA,
lysophosphatidic acid; PA, phosphatidic acid; DAG, diacylglycerol; TAG, triacylglycerol; PS, phosphatidylserine; LPS, lysophosphatidylserine; PE,
phosphatidylethanolamine; LPE, lysophosphatidylethanolamine; PC, phosphatidylcholine; LPC, lysophosphatidylcholine; PI, phosphatidylinositol; LPI,
lysophosphatidylinositol; PG, phosphatidylglycerol; PGP, phosphatidylglycerol phosphate; LPG, lysophosphatidylglycerol; CL, cardiolipin; CDP-DAG,
cytidinediphosphate-diacylglycerol; Ayr1p, 1-acyl dihydroxyacetone phosphate reductase; Gat1p or Gat2p, Glycerol-3-phosphate acyltransferase;
Slc1p, 1-acyl-sn-glycerol-3-phosphate acyltransferase (sphingolipid compensation); Lpt1p, lysophospholipid acyltransferase; Cst26, chromosome
stability; Pah1p, Phosphatidic acid phosphohydrolase; Dga1p, Diacylglycerol acyltransferase; Lro1p, Lecithin cholesterol acyl transferase Related Open
reading frame; Cds1p, CDP-diacylglycerol Synthase; Pgs1p, Phosphatidylglycerolphosphate synthase; Crd1p, Cardiolipin synthase; Pis1p,
Phosphatidylinositol synthase; Cho1, Phosphatidylserine synthase (choline requiring); Psd1p/Psd2p, Phosphatidylserine decarboxylase; Cho2p,
Phosphatidylethanolamine methyltransferase (choline requiring); Opi3p, Phospholipid methyltransferase (overproducer of inositol); Ept1p, sn-1,2-
diacylglycerol ethanolamine- and cholinephosphotranferase; Cpt1p, Cholinephosphotransferase.
doi:10.1371/journal.pone.0011956.g006
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Slc1p is likely the main acyltransferase to incorporate short-chain




Chloroform and methanol were purchased from Merck (Merck
Pte. Ltd., Singapore). Piperidine was purchased from Sigma-
Aldrich (St. Louis, MO, USA). Deionized water was obtained from
a MilliQ purification system (Millipore, Bedford, MA, USA).
Yeast strains and media
The strains used for this study were purchased from the
EUROSCARF library. BY4741 is a wild-type strain, whereas
Dslc1 and Dcst26 are deletion mutants for genes encoding the
respective acyltransferases. Strains were grown on YPD medium
(1% yeast extract, 2% Bacto-peptone, and 2% glucose) or
synthetic complete medium prepared as described [23]. The cells
were grown to an OD (600 nm) of 0.8–0.9 and harvested by
centrifugation at 3500 rpm for 2 min. Cell pellets were washed
with MilliQ water and transferred to 2-ml Eppendorf tubes and
stored at 280uC.
CST26 mutant transformation
The plasmid YCplac111-scGFP, with ampicillin and leucin
selection markers, was used in the construction of a GFP tagged
Cst26. The CST26 gene with its native promoter was amplified
with overhanging sequences containing restriction digestion sites
for the enzymes BamH1 (59GCGGGATCCAAAAATAAAA-
CAATAAAGTT39) and HindIII (59GCGAAGCTTGCCCTCT-
TTGGATATGCAG39). The PCR product and the plasmid
Ycplac111 was ligated, and the resulting plasmid was isolated and
transformed into the CST26 mutant as described earlier[36].
Fluorescence imaging of yeast cells
Fluorescence imaging was performed on a Leica DMLB
microscope (Wetzlar, Germany) with a Curtis 100 fluorescent
lamp. GFP signals were visualized with a 470/40-nm bandpass
excitation filter, a 500-nm dichromatic mirror, and a 525/50-nm
bandpass emission filter (Leica filter cube GFP).
Lipid extraction
Lipids were extracted as described with a slight modification of
a previously described method [37]. Briefly, 150 ml of acid-washed
glass beads and 900 ml of chloroform:methanol (1:2) were added to
the cell pellet and vortexed for 10 min at 4uC. The tubes were
transferred into a vacuum container and incubated overnight at
4uC with shaking at 1100 rpm, then 300 ml of chloroform and
300 ml of H2O were added. The mixture was vortexed for 30 s
and then incubated on ice for 2 min. The tubes were then
centrifuged at 9000 rpm for 2 min, and the lower organic phase
was collected. Chloroform (500 ml) and 50 ml of 2 M HCl were
added for the second extraction. The two organic extracts were
combined and dried using a Speed-Vac (Thermo Savant, Milford,
USA). The dried lipid film was stored at 280uC and reconstituted
in chloroform:methanol (1:1) before analysis by high-performance
liquid chromatography coupled with MS (HPLC/MS).
Rapid prescreening of fatty acyl composition in yeast
phospholipids using flow injection
An Agilent HPLC system coupled with an Applied Biosystems
Triple Quadrupole/Ion Trap mass spectrometer (4000Qtrap,
Foster City, CA) and Applied Biosystems Triple Quadrupole/Ion
Trap mass spectrometer (3200Qtrap) were used to analyze
individual lipids. Sample (20 ml) was directly introduced into the
mass spectrometer by loop injections with chloroform:metha-
nol:200 mM piperidine (1:1:0.05) as a mobile phase at a flow rate
of 250 ml/min [20;23]. Mass spectrometry was recorded in the
negative ESI modes, and ESI conditions were: turbo spray source
voltage, 24500 V; source temperature, 250uC; GS1: 40.00, GS2:
30.00, curtain gas: 25. Based on product ion and precursor ion
analysis of head groups and fatty acyls, a comprehensive list of
MRM transitions was then generated to follow fatty acyl
compositions of these lipids (parent R fatty acyl fragment
transitions) (Figure 2) [23]. For phospholipids, phosphatidylinositol
(PI), phosphatidylethanolamine (PE), phosphatidylserine (PS) and
phosphatidylglycerol (PG), MRM transitions of [M2H]21 over
individual fatty acyl ions were directly used for profiling. For
phosphatidylcholine, MRM transitions of [M+Cl]21 over individ-
ual fatty acyl ions were used for PC comparison. The signal
intensity of each MRM value was normalized to the sum of MRM
intensities of all species. Analysis was carried out in quadruplicate
for each genotype, using individual lipid extracts as per culture.
The Student t-test was used to determine the statistical significance
of differences between values.
Quantitative analysis of lipids using HPLC/MS
Although the above-described approach provides a fast,
sensitive means to screen for substrates of potential acyltrans-
ferases, individual lipid species were further analyzed after normal-
phase LC separation. Individual classes of polar lipids were
separated using an Agilent 1200 HPLC system and a 3200 Q-
Trap mass spectrometer (Applied Biosystems). The HPLC system
contained an Agilent 1200 binary pump, an Agilent 1200 thermo
sampler, and an Agilent 1200 column oven (Shui et al.,
unpublished work). HPLC conditions: Luna 3-mm silica column
(i.d. 15062.0 mm); mobile phase A (chloroform:methanol:ammo-
nium hydroxide, 89.5:10:0.5), B (chloroform:methanol:ammo-
nium hydroxide:water, 55:39:0.5:5.5); flow rate 300 ml/min; 5%
B for 3 min, then linearly switched to 30% B in 24 min and
maintained for 5 min, and then linearly changed to 70% B in
5 min and maintained for 7 min. Then, the composition of the
mobile phase was returned to the original ratio] over 5 min and
maintained for 6 min before the next sample was analyzed. Mass
spectrometry conditions were similar to those described above for
the 4000 Qtrap MS. Over 500 MRM transitions for individual
PG, PE, PC, PI, PS and PA species were set up at different elution
stages for LC-MS analysis (Table S1). Individual lipid species were
quantified by comparison with spiked internal standards PC-19:0/
19:0, PE-17:0-17:0, PS-14:0/14:0, PA-17:0/17:0, PG-14:0/14:0,
which were obtained from Avanti Polar Lipids (Alabaster, AL,
USA). Dioctanoyl phosphatidylinositol PI-8:0/8:0 (Echelon Bio-
sciences, Inc., Salt Lake City, UT, USA) was used to quantify
phosphatidylinositol.
Neutral lipids were analyzed by HPLC/ESI/MS [37]. Triglyc-
erides were separated from polar lipids on an Agilent Zorbax
Eclipse XDB-C18 column (i.d. 4.66150 mm). Selective ion
monitoring was used to record major phospholipids, sterols and
TAG species.
Assay of LPAAT activity for Slc1p and Cst26p
The acyltransferase assay was performed as described by Gijon
et al (32) using microsomes from yeast with some modifications.
Briefly, LPAAT activity was measured by the transfer of acyl-
CoAs to LPA to form PA. Reactions contained 50 mM Tris-HCl
(pH 7.5), 1 mM EDTA, 18:0, 18:1, 17:0, 16:1, 16:0, 14:0, 12:0, or
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10:0 FA-CoAs (0.04 mM each), 25 mM of C17-LPA, and
microsomes from yeast (30 mg of protein) in a total volume of
200 ml. After incubation at 37uC for 10 min, reactions were
stopped by the addition of 300 ml of chloroform:methanol (1:2).
Analysis of PA was performed using fatty acyl–based MRM
analysis as described above and HPLC-based approaches with
MRM of the following specific transitions: m/z 689.6R269.2,
687.6R269.2, 675.6R269.2, 661.6R269.2, 659.6R269.2,
633.6R269.2, 605.5R269.2 and 577.5R269.2 for PA17:0/18:0,
PA17:0/18:1, PA17:0/17:0, PA17:0/16:0, PA17:0/16:1, PA17:0/
14:0, PA17:0/12:0 and P17:0/10:0, respectively. FA-based MRM
transitions for PA analysis were also set up using fragmental ions of
incorporated fatty acyls 18:0 (m/z 283.2), 18:1 (m/z 281.2), 16:0
(m/z 255.2), 16:1 (m/z 253.2), 14:0 (m/z 227.2), 12:0 (199.1) and
10:0 (FA171.1), respectively. Levels of individual PA species were
calculated using spiked internal standard PA14:0/14:0 (Avanti)
with an MRM transition of 591.5R227.2.
Supporting Information
Table S1 MRM transitions of individual phospholipids.
Found at: doi:10.1371/journal.pone.0011956.s001 (0.08 MB
PDF)
Figure S1 Unbiased lipid profiling of the SCL1 mutant. (A)
Normalized lipid profile for the wild type; (B) normalized lipid
profile for the SCL1 mutant; (C) differential plot of the SCL1
mutant compared to wild type; (D) and (e) precursor ion scan of
ions at m/z 241 in wild type (WT) and DSLC1, respectively.
Found at: doi:10.1371/journal.pone.0011956.s002 (0.59 MB
PDF)
Figure S2 CST26 contains an acyltransferase domain. The
domain information of YBR042C shows that it possesses a 1-
acylglycerol-3-phosphate acyltransferase domain PTHR10983.
Found at: doi:10.1371/journal.pone.0011956.s003 (0.05 MB
PDF)
Figure S3 Unbiased lipid profiling of CST26 mutant. (A)
Normalized lipid profile for the wild type; (B) normalized lipid
profile for CST26 mutant; (C) differential plot of DCST26
compared to wild type; precursor ion scan of ions at m/z 283.1
(stearic acid) in wild-type (D) and cst26D cells (E).
Found at: doi:10.1371/journal.pone.0011956.s004 (0.31 MB
PDF)
Figure S4 Mass spectrometric profile of a CST26 mutant (A) or
of a CST26 mutant transformed with GFP-tagged CST26 (B). The
profile for the transformed cells is similar to the wild-type profile
(not shown), indicating that the level of m/z value 863 is restored
and the relative ratio of m/z values 807 and 835 is also restored.
Found at: doi:10.1371/journal.pone.0011956.s005 (0.05 MB
PDF)
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